29a promotes osteoblast proliferation by downregulating DKK-1 expression and activating Wnt/β-catenin signaling pathway.
Introduction
Osteoblasts and osteoclasts are the 2 major types of bone cells involved in the bone remodeling process. Bone mass is regulated both by the number of mature osteoblasts and by their bone-forming activity. 1 Osteoblasts come from mesenchymal stem cells (MSCs) which have multipotent differentiation potential. They can eventually become bone cells after cell proliferation, differentiation and mineralization, thus promoting bone formation and maintaining bone mass. Multiple signaling pathways have been found to be able to regulate osteoblast differentiation, i.e., BMP/Smads and Wnt/β-catenin. 2 MicroRNA (miRNA) is a class of noncoding singlestrand RNA molecules encoded by endogenous genes, with a length of 19-25 nucleotides; it is highly conserved among species. The miRNA usually acts on 1 or more messenger RNAs (mRNA) and negatively regulates gene expression by degrading mRNA or inhibiting its translation level. Some miRNAs were reported to regulate stem cell differentiation into osteoblast and bone formation. 3, 4 MicroRNA-29 has been found to be the key regulator in bone formation, absorption, remodeling, and repair. Human miR-29 includes miR-29a-3p, miR-29b1, miR-29b2, and miR-29c. MicroRNA-29a signaling has been found to protect against glucocorticoid-induced disturbance of Wnt and DKK-1 activity and to improve osteoblast differentiation and mineral acquisition. 5, 6 MicroRNA-29b has been functionally characterized as a positive regulator of osteoblastogenesis. 7 Previous studies have confirmed that in primary cultures of murine calvarial osteoblasts, expression of miR-29 family members did increase in osteoblastic differentiation progression. 8, 9 MicroRNA-29a could promote osteogenic differentiation of mesenchymal stem cells by targeting HDAC4. 10 As a key signaling protein of the Wnt signaling pathway, β-catenin also plays an important role in postnatal bone development and bone maintenance in mice. The mutation of the β-catenin gene can induce bone loss and increase the number of osteoclasts in mice. 11 It can also induce ectopic chondrocyte formation and inhibit normal osteogenesis by selectively knocking out the β-catenin gene in the MSCs which are differentiated into osteoblast cell lines. 12 In addition, the related antagonists of the Wnt/βcatenin signaling pathway -such as dickkopfs (DKKs), secretory curl-related proteins and bone sclerosis protein -can also act on the Wnt and LRP5/6 receptors, and can indirectly regulate bone mass and osteogenic differentiation. 13 The Wnt/β-catenin signaling pathway is composed of extracellular factor Wnt, transmembrane receptor, β-catenin, "degradation complex", and transcription factor T cytokines. The transmembrane receptors are composed of 2 kinds of proteins: one is a member of the 7 transmembrane crimp protein receptor family and the other is LRP5/6, a member of the low-density-lipoprotein-receptor-related protein (LRP) family. Regular Wnt signals are activated only when the curl protein and LRP are combined with Wnt. Therefore, restricting the expression of LRP or Wnt can block the Wnt/β-catenin pathway, indicating that the expression level of dickkopf-1 (DKK-1) is related to the Wnt/catenin pathway, which contributes to the differentiation of osteoblasts.
In this study, we analyzed the role of miR-29a and DKK-1 in osteoblast differentiation. These findings will help to provide new insights for the treatment of this disease.
Material and methods

Subjects
Specimens were collected from the surgical resection of AS pathological tissue and some normal tissues from the Department of Spinal Surgery at the First Affiliated University Hospital of Anhui Medical University, Hefei, China, from June to December 2017. All subjects signed informed consent forms and the study was approved by the ethics committee of Anhui Medical University.
Cell culture
Human osteoblast cells from cell line hFOB1. 19 were purchased from the American Type Culture Collection (ATCC; Manassas, USA). The cells were cultured with Dulbecco's modified Eagle medium (DMEM/F12) (HyClone; GE Healthcare Life Sciences, Logan City, USA) containing 10% fetal bovine serum (FBS) (HyClone; GE Healthcare Life Sciences), 0.03 mg/mL of G418, 100 U/mL of penicillin G, and 100 U/mL of treptomycin sulfate (Invitrogen, Carlsbad, USA). Nthyori 3-1 cells were cultured with HG RPMI1640 medium containing 10% FBS, 100 U/mL of penicillin G and 100 U/mL of treptomycin sulfate (Invitrogen) at 37°C in a humidified atmosphere with 5% CO 2 .
RNA extraction and qRT-PCR
The total RNA was extracted using a Trizol reagent kit (Invitrogen) according to the manufacturer's protocol. RNA concentration and purity were measured using a Qubit Fluorometer (Thermo Fisher Scientific, Waltham, USA). A total of 1 μg of RNA was subjected to reverse transcription using a MMLV Reverse Transcriptase Kit (Takara Bio China Inc., Dalian, China). Quantitative polymerase chain reaction (qPCR) was performed using a GenePharma Hairpin-it TM microRNA RT-PCR Quantitation Kit (Suzhou GenePharma Inc., Suzhou, China). The form of miRNA was mature, the primer was specific for 3p and the 2-ΔΔCT quantification method was used. The thermocycling conditions were as follows: pre-degeneration at 95°C for 10 min, followed by 40 cycles of 95°C for 12 s and 62°C for 40 s; U6 and GAPDH genes were used as an internal control. The primers used in this study were as follows:
DKK-1 (accession number: NM_012242.3) forward: 5'-TG-GAACTCCCCTGTGATTGC-3' and reverse: 5'-AATAG-GCAGTGCAGCACCTT-3'; β-catenin (accession number: NM_957217.4) forward: 5'-GCGTTAACCTGCCTTT-GAGC-3' and reverse: 5'-CTGGGCTGGCATGTAACT-CA-3'; U6 forward: 5'-CTCGCTTCGGCAGCACA-3' and reverse: 5'-AACGCTTCACGAATTTGCGT-3'; GAPDH forward: 5'-ACCTGACCTGCCGTCTAGAA-3' and reverse: 5'-TCCACCACCCTGTTGCTGTA-3'.
Small interfering (si) RNA transfection
The cells were randomly divided into 4 groups: control, DKK-1 overexpression, DKK-1 siRNA, and miR-29a. MicroRNA-29a mimics, DKK-1 overexpression lysates and DKK-1 siRNAs were purchased from Hanbio Biotechnology Co., Ltd. (Shanghai, China). The mimic used in transfection was specific for 3p. They were transfected into the hFOB1.19 cells. All siRNA transfections were performed using Lipofectamine 2000 Reagent (Life Technologies, Carlsbad, USA), according to the manufacturer's recommendations.
Western blotting
The cells in the logarithmic growth period were harvested and lysed with Cell Lysis Solution (Sigma-Aldrich, St. Louis, USA); they were then centrifuged at 10,000 rpm at 4°C for 5 min. The nucleus and plasma proteins were extracted using a Nuclear and Cytoplasmic Protein Extraction Kit (Beyotime, Shanghai, China) according to manufacturer's instructions. The proteins were loaded on 10% sodium dodecyl sulfate (SDS)-polyacrylamide gels (50 μg per lane) and transferred onto polyvinylidene fluoride membranes (PVDF; Amersham Biosciences, Piscataway, USA). The membranes were blocked for 2 h at 37°C with 5% non-fat milk in Tris-buffered saline with Tween 20 (TBST) and were incubated overnight at 4°C with primary antibodies, all sourced from Abcam (Cambridge, UK): 1:1000 DKK1; 1:1000 Wnt; 1:1000 β-catenin; 1:1000 p-β-catenin; 1:1000 caspase3; 1:1000 caspase 12; and 1:2000 GAPDH. Then, they were incubated with an HRP-conjugated secondary antibody (1:50,000, Abcam) for 1 h at 37°C. The membranes were coated with ECL luminescence reagent (Perkin-Elmer Inc., Waltham, USA) and, after the film was washed 3 times, they were observed using an Imagequant LAS4000 (GE Healthcare, Tokyo, Japan). GAPDH was used for normalization.
Cell proliferation detection
Cell proliferation was measured with a Cell Counting Kit-8 (CCK-8; Dojindo, Kumamoto, Japan) according to the manufacturer's protocol. The cells in the logarithmic growth phase were digested with trypsin and inoculated into 96-well plates (2,000 cells/well); they were then cultured overnight. Into each well, 10 μL of CCK-8 solution was added. The A450 values were determined with an Epoch Microplate Spectrophotometer (Bio Tek, Winooski, USA) every day after culturing for 1-5 days in order to evaluate the proliferation of cells.
Cell migration and invasion assay
Cell migration and invasion were determined using a Transwell system (Corning, Inc., Corning, USA). The cells were trypsinized and re-suspended in serumfree medium and 0.1 mL of cells (300,000/mL) were added to the upper chamber of the 24-well Transwell system. The invasion assay was performed using Matrigel matrix (BD Biosciences, San Jose, USA) as a barrier through which the cells had to pass. The migration assay did not use Matrigel. The lower chamber had 0.6 mL of a medium containing 10% FBS added to it. The cells were incubated at 37°C for 12 h for the migration test and they continued to culture at 37°C for 24 h for the invasion test. The cells were fixed and stained with 0.1% crystal violet dye (Richard-Allan Scientific, San Diego, USA). They were washed twice with PBS. The stained cells were observed under an inverted microscope.
Apoptosis analysis
Cell apoptosis was analyzed with flow cytometry (FAC-Scan; BD Biosciences) using an Annexin V-FITC Analysis Kit (Beyotime) according to manufacturer's instructions. The cells in each group were cultured for 48 h under the same conditions before being harvested and digested with trypsin. The digested cells were washed with the pre-cooled PBS 3 times, and were then lightly resuspended by adding 195 μL of annexin V-FITC binding solution; 5 μL of annexin V-FITC was added and the solution was gently mixed. The cells were incubated at room temperature (20-25°C), avoiding light, for 10-20 min after 10 μL of propidium iodide staining solution was gently stirred in. They were detected using CELLQUEST software (BD Biosciences).
Double luciferase reporter gene analysis
The luciferase reporter gene plasmid pGL3-DKK-1 and a point-mutation of luciferase reporter gene, plasmid mut-pGL3-DKK-1, were constructed. The 293T cells were inoculated into 24-well plates and were cultured overnight; the luciferase reporter plasmid, Renilla luciferase and miR-29a-3p mimic or a control were transfected into the 293T cells simultaneously. The cells were split after culturing for 48 h using a Dual Luciferase Reporter Assay System (Promega, Madison, USA) according to manufacturer's instructions. The results were measured using a Panomics Luminometer (Affymetrix, Santa Clara, USA) after the luminescence reagent was added. Sea renin fluorescence was used as an internal reference.
Statistical analysis
Statistical analysis was performed using one-way analysis of variance (ANOVA) or Student's t-test with SPSS v. 17.0 software (SPSS Inc., Chicago, USA). The data are expressed as mean ± standard deviation (SD). A p-value <0.05 was considered to be statistically significant.
Results
Changes of miR-29a, DKK-1 and β-catenin expression in normal and AS tissues
A total of 10 cases of pathological AS tissues and normal tissues were detected with real-time polymerase chain reaction (RT-PCR) and western blotting. We found that the expression level of DKK-1 was higher in AS tissues than in normal tissues (p < 0.01). However, the expression levels of β-catenin and miR-29a were lower in AS tissues than in normal tissues (p < 0.01, Fig. 1 ).
Upregulation of miR-29a or downregulation of DKK-1 expression promoted β-catenin expression in hFOB1.19 cells
The RT-PCR showed that miR-29a expression was upregulated in the miR-29a group; there were no obvious changes in the other groups. Compared with the control group, the expression of DKK was upregulated in the DKK overexpression group, and it was downregulated in the DKK/ siRNA and miR-29a groups (p < 0.01). Western blotting showed that the expression of β-catenin, Cyt-β-catenin, Nuc-β-catenin, and Wnt in the DKK overexpression group was downregulated, while in the DKK/siRNA and miR-29a groups it was upregulated. The expression of p-β-catenin in the DKK overexpression group was upregulated, while it was downregulated in the DKK/siRNA and miR-29a groups (p < 0.01, Fig. 2 ). 
MicroRNA-29a promoted the proliferation of hFOB1.19 cells, while DKK-1 inhibited their proliferation
Cell proliferation was detected using a CCK-8 kit. It was found that the upregulation of DKK-1 in hFOB1.19 cells inhibited the proliferation of hFOB1.19 cells, while the upregulation of miR-29a or downregulation of DKK-1 promoted the proliferation of hFOB1.19 cells (p < 0.05, Fig. 3 ).
MicroRNA-29a inhibited the apoptosis of hFOB1.19 cells, while DKK-1 promoted their apoptosis
Flow cytometry showed that the upregulation of miR-29a or the downregulation of DKK-1 in hFOB1.19 cells inhibited cell apoptosis, while the upregulation of DKK-1 in hFOB1.19 cells promoted cell apoptosis. Both the upregulation of miR-29a and the downregulation of DKK-1 at the same time inhibited the expression of apoptotic Fig. 4 ).
MicroRNA-29a promoted the invasion and migration of hFOB1.19 cells, while DKK-1 inhibited invasion and migration
The Transwell assays showed that the upregulation of miR-29a or the downregulation of DKK-1 in hFOB1.19 cells promoted the invasion and migration of hFOB1.19 cells, while the upregulation of DKK-1 inhibited the invasion and migration of hFOB1.19 cells (p < 0.01, Fig. 5 ).
MicroRNA-29a targeted 3'UTR of DKK-1 and inhibited its expression
The bioinformatics analysis predicted that miR-29a-3p can directly act on the 3'UTR of DKK-1. Analysis of the double luciferase reporter gene showed that miR-29a-3p could act on the 3'UTR of DKK-1 and could inhibit the expression of luciferase (p < 0.01). When the 3'UTR domain of DKK-1 was point-mutated, the inhibitory effect of miR-29a-3p disappeared (Fig. 6 ).
Discussion
A previous study reported that the overexpression of miR-29a significantly enhanced the differentiation of HMSCs into osteoblasts, while the inhibition of miR-29a markedly blocked the osteoblastic differentiation of HMSCs. 10 In the current study, we found that miR-29a and DKK-1 played an important role in osteoblast differentiation. MicroRNA-29a promoted the proliferation of hFOB1.19 cells, while DKK-1 inhibited the proliferation of hFOB1.19 cells. MicroRNA-29a inhibited the apoptosis of hFOB1.19 cells, while DKK-1 promoted the apoptosis of hFOB1.19 cells. MicroRNA-29a promoted the invasion and migration of hFOB1.19 cells, while DKK-1 inhibited the invasion and migration of hFOB1.19 cells. Osteoblasts, as the main functional cells of bone formation, will gradually express specific markers, such as ALP, osteocalcin, serotype I procollagen C end peptide, etc., in the process of differentiation and maturation. At the same time, it is also regulated by a series of transcription factors, such as Runt-related transcription factor 2 (Runx2), Osterix/ Sp7, β-catenin, transcription-activating factor 4, nuclearfactor-activating protein 1, SMADs, DKK-1, etc. 14 They cooperate with each other to participate in the regulation of osteoblast differentiation and bone formation. In particular, all signaling pathways involved in the network directly or indirectly affect DKK-1, and ultimately regulate the expression of downstream target genes, thus they regulate osteoblast differentiation and bone formation. 15 It has been found that DKK1 inhibits the expression of Wnt3a and indirectly inhibits the activity of β-catenin. 16 In this study, we found that the expression level of DKK-1 was higher in AS tissues than in normal tissues. However, the expression levels of β-catenin and miR-29a were lower in AS tissues than in normal tissues. The expression of DKK-1 could be downregulated by the overexpression of miR-29a. On the contrary, altered expression of DKK-1 does not affect the expression of miR-29a, which suggests that DKK-1 is the downstream responder of miR-29a.
In the classical Wnt signaling pathway, Wnt proteins (Wnt1, Wnt3a, Wnt8a, and Wnt10b) inhibit the activity of β-catenin-degrading complex after binding to the transmembrane-specific receptor frizzled protein (Frz) and the low-density lipoprotein (LDL) receptor-related protein 5/6 (LRP5/6), so that the level of β-catenin in cells increases and the transcription of downstream target genes starts. Dickkopf-1 is an inhibitor of the classical Wnt signaling pathway; it can passivate LRP5/6 and weaken the binding of the Wnt protein to LRP5/6, thus inhibiting the activation of the classical Wnt signaling pathway. 17, 18 The Wnt signaling pathway is classified into classical and non-classical signaling pathways, based on whether or not β-catenin participates. The role of the classical Wnt signaling pathway (Wnt/β-catenin pathway) in osteoblasts is an important topic in studies on bone growth and development and bone metabolism.
MicroRNA-29a plays a key role in the process of osteogenic differentiation and is closely related to AS. Previous studies have indicated that miR29a is associated with bone formation. It suppressed osteonectin expression in osteoblasts by regulating the process of differentiation via the Wnt signaling pathway, and modulated osteoblast differentiation, playing an important role in skeletal remodeling and bone mass stability. 19, 20 It was found that when there was a lack of Wnt protein outside the cell, the β-catenin could be degraded, blocking the Wnt/β-catenin signaling pathway and inhibiting the proliferation and differentiation of osteoblasts. Wnt/β-catenin signaling plays a critical role in the achievement of peak bone mass, affecting the commitment of mesenchymal progenitors to the osteoblast lineage and determining the anabolic capacity of osteoblasts depositing bone matrix. [21] [22] [23] 
Conclusions
In brief, our results demonstrated that miR-29a could stimulate the proliferation, migration, invasion, and differentiation of osteoblasts by activating the Wnt/β-catenin pathway in hFOB1.19 cells and reducing the expression of DKK-1.
